Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Sarcopenia 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Diarrhea 2Vaso-Occlusive Crises 1Stomach Neoplasms 1Seaweed Associated Changes in Healthy Subjects 1Rectal Neoplasms 1Proctitis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Metabolic Syndrome 1Malnutrition 1Lymphoma 1Liver Failure 1Insulin Resistance 1Hyperandrogenism 1Head and Neck Neoplasms 1Glucose Intolerance 1Fibrosis 1Colonic Polyps 1Cholangiocarcinoma 1Chemotherapy-related Diarrhea 1Carcinoma, Hepatocellular 1Anovulation 1Anemia, Sickle Cell 1

Interventions

Octreotide 6Irinotecan 6Loperamide 5Probiotics 3Leucovorin 3Fluorouracil 3Fecal Microbiota Transplantation 3Calcium Aluminosilicate 3maltodextrin 2telotristat ethyl 1shosaiko-to 1lanreotide 1isatuximab 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1bile acid binding proteins 1XRP6258 1Theophylline 1Temozolomide 1Surveys and Questionnaires 1Sulfasalazine 1Sugars 1Standard of Care 1Raloxifene Hydrochloride 1Radiation 1Prednisone 1PHY 906 1Oxaliplatin 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Diarrhea × maltodextrin × Clear all
NCT06576986 2024-08-29

Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy

Federal University of Minas Gerais

Phase NA Recruiting
80 enrolled
GastrointestinalOther

Colonic Neoplasms, Diarrhea, Colorectal Neoplasms, Mucositis

NCT02819960 2022-12-14

Prevention of Irinotecan Induced Diarrhea by Probiotics

S&D Pharma SK s.r.o.

Phase 3 Completed
233 enrolled

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡